Chondroitin-ICCO caps. 0.25g 50 pc


Chondroitin-ICCO caps. 0.25g 50 pc



Active substance:
1 capsule contains: Sodium chondroitin sulfate – 250 mg.
Lactose (milk sugar), calcium stearate. Capsules Composition of gelatin: titanium dioxide, dye azorubin, dye Ponceau [Ponceau 4R] (Ponceau 4R), dye blue patented (blue V patent), the dye Brilliant Black (brilliant black BN), methyl parahydroxybenzoate (methyl hydroxybenzoate), propyl parahydroxybenzoate (propyl), acetic acid, gelatin.
Product form:
Capsules 250 mg.
Packaging 50 capsules.
Increased sensitivity to the drug;
Children up to age 15 years (due to the lack of accurate data)
Caution should be used in patients with bleeding, and patients with a tendency to bleeding.
Degenerative diseases of the joints and spine: osteoarthritis, osteochondrosis.
Interaction with other drugs
With simultaneous use of chondroitin-Akos with other drugs may enhance the action anticoagulants, antiplatelet agents, fibrinolytics.
In rare cases, possible symptoms of overdose symptoms of the gastrointestinal tract: nausea, vomiting, diarrhea; Propafenone excessively high doses (more than 3 g per day) are possible hemorrhagic lesions.
Treatment is symptomatic.
pharmachologic effect
Pharmacological group:
Tissue repair promoter.
It affects the metabolic processes in hyaline and fibrous cartilage, reduces degenerative changes in the cartilage of joints, stimulates the biosynthesis of glycosaminoglycans. Slows bone resorption and reducing calcium loss, accelerates bone regeneration. In drug treatment, Chondroitin-ICCO decreases pain and improves the mobility of the affected joints. The therapeutic effect persists for a long time after treatment.
More than 70% of chondroitin sulfate absorbed in the digestive tract. Bioavailability is 13%. In single ingestion sredneterapevticheskih dose maximum plasma concentration observed after 3-4 h in synovial fluid – 4-5 h The absorbed in the gastrointestinal tract the drug is accumulated in the synovial fluid.. Excreted by the kidneys.
Pregnancy and breast-feeding
The drug is not recommended for use during pregnancy and lactation because of lack of sufficient clinical data.
Conditions of supply of pharmacies
On prescription.
side effects
Rarely: allergic reactions (urticaria, erythema, pruritus), nausea, and vomiting.
Storage conditions
In a dry, dark place at a temperature not higher than 20 C. Keep out of reach of children.
Dosing and Administration
Inside, during or after a meal with at least 1/2 cup of water. Adults and adolescents from 15 years appoint 1 g per day – 2 capsules 2 times a day.
The recommended duration of the initial course of treatment is 6 months, the drug since its abolition – 3-5 months depending on the location and stage of the disease, duration of repeated courses of treatment is determined by your doctor.
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg


There are no reviews yet.

Add your review